FIELD: medicine.
SUBSTANCE: this invention relates to a method of photodynamic therapy (PDT) of bladder cancer. To do this, in adjuvant or neoadjuvant therapy, an aqueous solution of hexyl 5-ALA-ether (HAL) is administered in a concentration of 0.1 to 5 wt% and expose the inner part of the bladder to blue light. Exposure to light is carried out at a flow density of 1.5 to 12.5 MW/cm2, at a dose of 0.2 to 15.0 J/cm2.
EFFECT: such combined therapy in the developed mode provides a reduction in the frequency of relapses due to more accurate visualization of the tumor when exposed to blue light.
24 cl, 2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEO-ADJUVANT THERAPY FOR BLADDER CANCER | 2016 |
|
RU2783177C2 |
| INTRAVESICAL THERAPY FOR BLADDER CANCER | 2016 |
|
RU2779543C2 |
| METHOD OF TREATING SUPERFICIAL URINARY BLADDER CANCER | 2010 |
|
RU2448745C2 |
| METHOD OF TREATING RECURRENT SMALL PELVIC TUMORS | 2018 |
|
RU2695003C2 |
| METHOD OF FRACTIONATED PHOTODYNAMIC THERAPY OF BENIGN PROSTATE HYPERPLASIA | 2008 |
|
RU2367487C1 |
| METHOD OF TREATING PATIENTS WITH CHRONIC RECURRENT BACTERIAL CYSTITIS | 2023 |
|
RU2820135C1 |
| DEVICE FOR PHOTODYNAMIC THERAPY | 2016 |
|
RU2736406C2 |
| METHOD OF TREATING MALIGNANT BLADDER TUMOURS | 2009 |
|
RU2405601C1 |
| EMITTER | 2012 |
|
RU2615870C2 |
| SEMI-SOLID COMPOSITIONS AND PHARMACEUTICAL PRODUCTS | 2010 |
|
RU2526803C2 |
